Schroder Swiss Equity Core Fund I

Reference Data

ISIN CH0104078727
Valor Number 10407872
Bloomberg Global ID
Fund Name Schroder Swiss Equity Core Fund I
Fund Provider Schroder Investment Management (Switzerland) AG (LUX & CH) Zurich/Geneva, Switzerland
Web: https://www.schroders.com/en/ch/asset-management/
Phone: +41 (0) 800 844 448
E-Mail: info-sim@schroders.com
Fund Provider Schroder Investment Management (Switzerland) AG (LUX & CH)
Representative in Switzerland
Distributor(s) Schroder & Co Bank AG
Zürich
Phone: +41 44 250 11 11
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Switzerland
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** Schroder Swiss Equity Core Fund is an open-end fund incorporated in Switzerland. The Fund's objective is to obtain long-term capital growth. The Fund is actively managed and tries to exceeds the performance of Swiss Performance Index (SPI).
Peculiarities

Fund Prices

Current Price * 282.29 CHF 16.09.2025
Previous Price * 284.62 CHF 15.09.2025
52 Week High * 294.33 CHF 03.03.2025
52 Week Low * 245.51 CHF 09.04.2025
NAV * 282.29 CHF 16.09.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 16,759,527
Unit/Share Assets *** 14,897,442
Trading Information SIX

Performance

YTD Performance +7.75% 30.12.2024
16.09.2025
1 month -0.37% 18.08.2025
16.09.2025
3 months +0.12% 16.06.2025
16.09.2025
6 months -3.01% 17.03.2025
16.09.2025
1 year +4.16% 16.09.2024
16.09.2025
2 years +14.01% 18.09.2023
16.09.2025
3 years +23.49% 16.09.2022
16.09.2025
5 years +27.75% 16.09.2020
16.09.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Novartis AG Registered Shares 12.07%
Roche Holding AG 11.11%
Nestle SA 10.77%
Compagnie Financiere Richemont SA Class A 5.21%
Zurich Insurance Group AG 5.09%
UBS Group AG Registered Shares 3.95%
ABB Ltd 3.20%
Sandoz Group AG Registered Shares 3.19%
Partners Group Holding AG 2.72%
Galderma Group AG Registered Shares 2.58%
Last data update 31.08.2025

Cost / Risk

TER 0.09%
TER date 31.12.2024
Performance Fee ***
PTR
Max. Management Fee ***
Ongoing Charges *** 0.09%
SRRI ***
SRRI date *** 31.08.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)